Brief: Astrazeneca Pharma India Dec-Quarter PAT Falls
08/02/2021 12:48
Feb 8 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS :
* ASTRAZENECA PHARMA INDIA DEC-QUARTER PAT 210.5 MILLION
RUPEES
VERSUS PROFIT 267 MILLION RUPEES YEAR AGO
* ASTRAZENECA PHARMA INDIA DEC-QUARTER REVENUE FROM
OPERATIONS 2
BILLION RUPEES VERSUS 2.24 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE8F6G4H
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication